Nataliya Migulina

Nataliya Migulina

Auto-generated profile, based on publicly available information

Nataliya Migulina

University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen Research Institute for Asthma and COPD, Groningen, The Netherlands

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2022 in The FASEB Journal
Verified
Journal Article
Open access
NMNataliya Migulina
Nataliya Migulina
GTGavin Tjin
Gavin Tjin
AFAlen Faiz
Alen Faiz
TBTheo Borghuis
Theo Borghuis
FZFenghua Zhao
Fenghua Zhao
JBJanette K. Burgess
Janette K. Burgess
Chronic obstructive pulmonary disease (COPD) is characterized by long‐term airflow obstruction with cigarette smoke as a key risk factor. Extracellular matrix (ECM) alterations in COPD may lead to small airway wall fibrosis. Altered collagen cross‐linking, potentially mediated by the lysyl oxidase (LO) family of enzymes (LOX, LOXL1‐4), orchestrates disturbed ECM homeostasis. In this study, we investigated the effects of smoking status and presence and severity of COPD on LOs gene and protein expression in the airways and the impact of LOs inhibition on airway contraction in an ex vivo mouse model. We used gene expression data from bronchial brushings, airway smooth muscle (ASM) cells in vitro and immunohistochemistry in lung tissue to assess smoke‐ and COPD‐associated differences in LOs gene and protein expression in the small airways. We found higher LOX expression in current‐ compared to ex‐smokers and higher LOXL1 expression in COPD compared to non‐COPD patients. LOX and LOXL2 expression were upregulated in COPD ASM cells treated with cigarette smoke extract. LOXL1 and LOXL2 protein levels were higher in small airways from current‐ compared to non‐smokers. In COPD patients, higher LOXL1 and lower LOX protein levels were observed, but no differences for LOXL2, LOXL3, and LOXL4 protein were detected in small airways. Inhibiting LOs activity increased airway contraction in murine lung slices. COPD‐associated changes in LOs, in particular LOX and LOXL1, may be related to smoking and contribute to impaired airway function, providing potential novel targets for preventing or treating small airways changes in COPD.

1 January 2024 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
NMNataliya Migulina
Nataliya Migulina
RHRoderick Harold Jan de Hilster
Roderick Harold Jan de Hilster
SBSabine Bartel
Sabine Bartel
RVRolf H. J. Vedder
Rolf H. J. Vedder
MBMaarten van Den Berge
Maarten van Den Berge
JBJanette Burgess
Janette Burgess
With the introduction of complex three-dimensional (3-D) lung models, comes a need for understanding cellular behavior in these models. We compared gene expression profiles of human lung fibroblasts grown on two-dimensional (2-D) collagen I-coated surfaces with those in 3-D collagen I hydrogels. RNA sequencing and subsequent pathway analyses showed decreased proliferation, increased extracellular matrix (ECM) remodeling, and altered Hippo signaling and ECM deposition-related gene signatures. These findings highlight unique responses of fibroblasts in 3-D models.


9 September 2023 in European Respiratory Journal
Verified
Conference Paper
Closed access
NMNataliya Migulina
Nataliya Migulina
TBTheo Borghuis
Theo Borghuis
BRBen Roos
Ben Roos
WTWim Timens
Wim Timens
CPChristina Pabelick
Christina Pabelick
YPY.S. Prakash
Y.S. Prakash
Background: The lung is a mechanosensitive organ, where cells experience a range of mechanical forces. Chronic obstructive pulmonary disease (COPD) involves abnormal macroscopic and cellular changes that impact the mechanical properties of the lung and the extracellular matrix (ECM). The Piezo (PZ) family - PZ1/2, are mechanosensitive channels expressed, among others, on airway smooth muscle (ASM) that mediate cellular responses to stretch and ECM biomechanics. The role and expression of PZs in COPD lung ASM is not known. We hypothesize that PZ expression, regulation and activation is altered in COPD lung ASM and involved in ECM regulation. Methods: Distribution and expression of PZ proteins in lung tissue was assessed using IHC comparing COPD stage IV to control (n=10/group). The area and intensity of staining ASM was quantified using ImageJ. Isolated ASM cells from control and COPD stage II and IV (n=6) patients were exposed to the PZ1 agonist Yoda1 and/or stretch for 24h, followed by measuring gene and protein expression of PZs and ECM genes. Results: Area and intensity of PZ1 and PZ2 staining was higher in COPD IV ASM compared to control. Gene expression of PZ1 increased upon stretching in control but not in COPD ASM cells, while PZ2 protein expression decreased upon stretching in combined groups. Yoda1 treatment resulted in decreased Collagen1, fibulin1 and periostin gene expression in ASM cells of the combined groups. Conclusion: Higher PZs expression in COPD lung ASM together with altered PZ response to stretching and decreased ECM gene expression upon PZ activation, supports a potential role for PZ activation in abnormal ECM-ASM crosstalk in COPD.

17 June 2026 in bioRxiv
Verified
Preprint
Open access
NMNataliya Migulina
Nataliya Migulina
BRBen Roos
Ben Roos
TBTheo Borghuis
Theo Borghuis
MNMaunick Lefin Koloko Ngassie
Maunick Lefin Koloko Ngassie
LDLi Drake
Li Drake
YPY. S. Prakash
Y. S. Prakash
As an intrinsically mechanosensitive organ, the lung experiences a range of mechanical forces. Chronic obstructive pulmonary disease (COPD) involves abnormal macroscopic cellular and extracellular matrix (ECM) changes that impact mechanical properties of the lung. Mechanosensitive Piezo1/2 channels are expressed in the lung including on airway smooth muscle cells (ASM) that mediate cellular responses to stretch and ECM biomechanics. The expression and roles of Piezos in COPD lung ASM are not known. We hypothesized that Piezo expression and activation are altered in COPD lung ASM influencing ECM regulation. Distribution of Piezo proteins in ASM and epithelium of small airways of COPD stage II and IV vs. non-COPD controls was assessed using immunohistochemistry and ImageJ (n=10-17/group). Isolated ASM cells from control (n=6) vs. COPD stage II and IV patients (n=3 each stage) were exposed to stretch or the Piezo1 agonist Yoda1 followed by measurement of ECM gene and protein expression. Less Piezo2 staining was observed in COPD IV patients compared to controls, with lesser area and intensity of staining in the epithelial layer, and lower intensity of staining in ASM and small airways as a whole. Fura-2-based imaging of ASM Ca 2+ showed lower influx after Yoda1 exposure in COPD II compared to control and COPD IV. Gene expression of Piezo1 increased upon stretching in controls but not in COPD ASM, while Piezo2 protein expression decreased with stretching in all groups. Yoda1 treatment resulted in decreased collagen1 , fibulin1 and periostin gene and collagen 1 and periostin protein expression in ASM. Overall, these results support a role for Piezo activation in abnormal ECM-ASM cell crosstalk in COPD.